FDA Okays Cenobamate (Xcopri) for Focal Epilepsy FDA Okays Cenobamate (Xcopri) for Focal Epilepsy

The FDA has approved cenobamate for seizures in adults with focal epilepsy based on results from two trials of more than 600 patients, as well as a 1300-person safety study.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Alert Source Type: news